Contracts to purchase tests could be signed as soon as next week, but relief could be weeks away for people trying to buy the hard-to-find tests.
President Biden promised Americans he is making 500 million coronavirus tests available free of charge, but help is at least weeks away — if not longer — for anxious Americans facing a surge of new virus cases. Mr. Biden’s administration has not yet signed a contract to buy the tests, and the website to order them will not be up until January. Officials have not said how many tests people will be able to order or how quickly they will be shipped once they begin to be available next month. Manufacturers say they are already producing tests as fast as they can. As a candidate, Mr. Biden excoriated the lack of testing during the Trump administration, saying in March 2020 that “the administration’s failure on testing is colossal, and it’s a failure of planning, leadership and execution.” But the Omicron variant caught the White House off guard, as the president has acknowledged, and cases have far outstripped the government’s ability to make tests available. The president’s pledge of a half-billion tests on Tuesday was the centerpiece of a newly aggressive testing effort, announced just days before Christmas, as Americans try to find the hard-to-find tests so they know whether they are infected during the holiday season. “That’s not a plan — it’s a hope,” said Jennifer Nuzzo, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health, which tracks testing trends. “If those tests came in January and February, that could have an impact, but if they are spread out over 10 to 12 months, I’m not sure what kind of impact it is going to have.” Contracts to purchase tests could be finalized as soon as next week, officials said. Whether testing manufacturers can now ramp up to produce an extra 500 million at-home tests — and how soon — is unclear. John M. Koval, a spokesman for Abbott Laboratories, a major manufacturer of rapid at-home antigen tests, said in an email message that the company is seeing “unprecedented demand” for its tests, “and we’re sending them out as fast as we can make them.” The company is running its manufacturing plants around the clock, investing in automation and hiring more workers, Mr. Koval said. Abbott will make 70 million tests in January, he said, and “can scale significantly in the months ahead.” Ellume, an Australian manufacturer of a competing rapid test, said in a statement that it “stands ready to meet the increased demand” by supplying the government 8.5 million tests, and opening a new manufacturing facility in Frederick, Md.
